BindingDB logo
myBDB logout

PubMed code 18755586

Compile data set for download or QSAR
Found 32 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265139
PNG
((2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethylbenzyl)phen...)
Show SMILES CCc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1
Show InChI InChI=1/C21H25ClO5/c1-2-12-3-5-13(6-4-12)9-15-10-14(7-8-16(15)22)21-20(26)19(25)18(24)17(11-23)27-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 12n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265176
PNG
((2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)ph...)
Show SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O)cc2)c1
Show InChI InChI=1/C19H21ClO6/c20-14-6-3-11(8-12(14)7-10-1-4-13(22)5-2-10)19-18(25)17(24)16(23)15(9-21)26-19/h1-6,8,15-19,21-25H,7,9H2/t15-,16-,17+,18-,19+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 33n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265178
PNG
(CHEMBL521565 | N-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-...)
Show SMILES CN(Cc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)c1ccccc1
Show InChI InChI=1/C28H30ClNO6/c1-30(28(35)19-5-3-2-4-6-19)15-18-9-7-17(8-10-18)13-21-14-20(11-12-22(21)29)27-26(34)25(33)24(32)23(16-31)36-27/h2-12,14,23-27,31-34H,13,15-16H2,1H3/t23-,24-,25+,26-,27+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 45n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265236
PNG
(5-(4-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihy...)
Show SMILES CN(C)c1ccc2c(-c3ccc(cc3C([O-])=O)C(=O)NCc3ccc(COc4ccc(Cc5cc(ccc5Cl)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4)cc3)c3ccc(cc3oc2c1)=[N+](C)C
Show InChI InChI=1/C52H50ClN3O10/c1-55(2)35-13-18-39-43(24-35)65-44-25-36(56(3)4)14-19-40(44)46(39)38-17-11-33(23-41(38)52(62)63)51(61)54-26-30-5-7-31(8-6-30)28-64-37-15-9-29(10-16-37)21-34-22-32(12-20-42(34)53)50-49(60)48(59)47(58)45(27-57)66-50/h5-20,22-25,45,47-50,57-60H,21,26-28H2,1-4H3,(H-,54,61,62,63)/t45-,47-,48+,49-,50+/s2
UniProtKB/SwissProt

GoogleScholar
CHEBI
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 55n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265239
PNG
(3-(3-((4-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-t...)
Show SMILES CN(Cc1ccc(COc2ccc(Cc3cc(ccc3Cl)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C42H45BClF2N3O7/c1-25-18-26(2)48-36(25)21-33-12-11-32(49(33)43(48,45)46)13-17-38(51)47(3)22-28-4-6-29(7-5-28)24-55-34-14-8-27(9-15-34)19-31-20-30(10-16-35(31)44)42-41(54)40(53)39(52)37(23-50)56-42/h4-12,14-16,18,20-21,37,39-42,50,52-54H,13,17,19,22-24H2,1-3H3/t37-,39-,40+,41-,42+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 95n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265235
PNG
(24-[({6-[4-({2-chloro-5-[(2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CC1(C)C2=C3C=C4C(CC[N+]5=C4C(C)(C)c4cc(ccc54)S([O-])(=O)=O)OC3CCN2c2ccc(CC(=O)NCCCCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)cc12
Show InChI InChI=1/C56H64ClN3O11S/c1-55(2)40-26-33(11-17-43(40)59-22-19-45-38(53(55)59)30-39-46(70-45)20-23-60-44-18-15-37(72(66,67)68)29-41(44)56(3,4)54(39)60)27-48(62)58-21-7-5-6-8-24-69-36-13-9-32(10-14-36)25-35-28-34(12-16-42(35)57)52-51(65)50(64)49(63)47(31-61)71-52/h9-18,26,28-30,45-47,49-52,61,63-65H,5-8,19-25,27,31H2,1-4H3,(H-,58,62,66,67,68)/t45?,46?,47-,49-,50+,51-,52+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 102n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265233
PNG
(24-[({4-[4-({2-chloro-5-[(2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CN(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)Cc1ccc2N3CCC4OC5CC[N+]6=C(C5=CC4=C3C(C)(C)c2c1)C(C)(C)c1cc(ccc61)S([O-])(=O)=O
Show InChI InChI=1/C55H62ClN3O11S/c1-54(2)39-25-32(10-16-42(39)58-21-18-44-37(52(54)58)29-38-45(69-44)19-22-59-43-17-14-36(71(65,66)67)28-40(43)55(3,4)53(38)59)26-47(61)57(5)20-6-7-23-68-35-12-8-31(9-13-35)24-34-27-33(11-15-41(34)56)51-50(64)49(63)48(62)46(30-60)70-51/h8-17,25,27-29,44-46,48-51,60,62-64H,6-7,18-24,26,30H2,1-5H3/t44?,45?,46-,48-,49+,50-,51+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 122n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265238
PNG
(3-(3-(4-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCc3ccc(COc4ccc(Cc5cc(ccc5Cl)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C41H43BClF2N3O7/c1-24-17-25(2)47-35(24)20-32-11-10-31(48(32)42(47,44)45)12-16-37(50)46-21-27-3-5-28(6-4-27)23-54-33-13-7-26(8-14-33)18-30-19-29(9-15-34(30)43)41-40(53)39(52)38(51)36(22-49)55-41/h3-11,13-15,17,19-20,36,38-41,49,51-53H,12,16,18,21-23H2,1-2H3,(H,46,50)/t36-,38-,39+,40-,41+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 123n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265234
PNG
(24-[({4-[4-({2-chloro-5-[(2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CCN(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)Cc1ccc2N3CCC4OC5CC[N+]6=C(C5=CC4=C3C(C)(C)c2c1)C(C)(C)c1cc(ccc61)S([O-])(=O)=O
Show InChI InChI=1/C56H64ClN3O11S/c1-6-58(21-7-8-24-69-36-13-9-32(10-14-36)25-35-28-34(12-16-42(35)57)52-51(65)50(64)49(63)47(31-61)71-52)48(62)27-33-11-17-43-40(26-33)55(2,3)53-38-30-39-46(70-45(38)19-22-59(43)53)20-23-60-44-18-15-37(72(66,67)68)29-41(44)56(4,5)54(39)60/h9-18,26,28-30,45-47,49-52,61,63-65H,6-8,19-25,27,31H2,1-5H3/t45?,46?,47-,49-,50+,51-,52+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 131n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265232
PNG
(24-[({4-[4-({2-chloro-5-[(2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CC1(C)C2=C3C=C4C(CC[N+]5=C4C(C)(C)c4cc(ccc54)S([O-])(=O)=O)OC3CCN2c2ccc(CC(=O)NCCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)cc12
Show InChI InChI=1/C54H60ClN3O11S/c1-53(2)38-24-31(9-15-41(38)57-20-17-43-36(51(53)57)28-37-44(68-43)18-21-58-42-16-13-35(70(64,65)66)27-39(42)54(3,4)52(37)58)25-46(60)56-19-5-6-22-67-34-11-7-30(8-12-34)23-33-26-32(10-14-40(33)55)50-49(63)48(62)47(61)45(29-59)69-50/h7-16,24,26-28,43-45,47-50,59,61-63H,5-6,17-23,25,29H2,1-4H3,(H-,56,60,64,65,66)/t43?,44?,45-,47-,48+,49-,50+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 145n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265230
PNG
(3-(3-(6-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tri...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C39H47BClF2N3O7/c1-24-19-25(2)45-33(24)22-30-11-10-29(46(30)40(45,42)43)12-16-35(48)44-17-5-3-4-6-18-52-31-13-7-26(8-14-31)20-28-21-27(9-15-32(28)41)39-38(51)37(50)36(49)34(23-47)53-39/h7-11,13-15,19,21-22,34,36-39,47,49-51H,3-6,12,16-18,20,23H2,1-2H3,(H,44,48)/t34-,36-,37+,38-,39+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 148n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265237
PNG
(5-((4-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trih...)
Show SMILES CN(C)c1ccc2c(-c3ccc(cc3C([O-])=O)C(=O)N(C)Cc3ccc(COc4ccc(Cc5cc(ccc5Cl)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4)cc3)c3ccc(cc3oc2c1)=[N+](C)C
Show InChI InChI=1/C53H52ClN3O10/c1-55(2)36-14-19-40-44(25-36)66-45-26-37(56(3)4)15-20-41(45)47(40)39-18-12-34(24-42(39)53(63)64)52(62)57(5)27-31-6-8-32(9-7-31)29-65-38-16-10-30(11-17-38)22-35-23-33(13-21-43(35)54)51-50(61)49(60)48(59)46(28-58)67-51/h6-21,23-26,46,48-51,58-61H,22,27-29H2,1-5H3/t46-,48-,49+,50-,51+/s2
UniProtKB/SwissProt

GoogleScholar
CHEBI
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 154n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265226
PNG
(3-(3-((4-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CN(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C38H45BClF2N3O7/c1-23-18-24(2)44-32(23)21-29-10-9-28(45(29)39(44,41)42)11-15-34(47)43(3)16-4-5-17-51-30-12-6-25(7-13-30)19-27-20-26(8-14-31(27)40)38-37(50)36(49)35(48)33(22-46)52-38/h6-10,12-14,18,20-21,33,35-38,46,48-50H,4-5,11,15-17,19,22H2,1-3H3/t33-,35-,36+,37-,38+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 155n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265223
PNG
(3-(3-(3-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tri...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C36H41BClF2N3O7/c1-21-16-22(2)42-30(21)19-27-8-7-26(43(27)37(42,39)40)9-13-32(45)41-14-3-15-49-28-10-4-23(5-11-28)17-25-18-24(6-12-29(25)38)36-35(48)34(47)33(46)31(20-44)50-36/h4-8,10-12,16,18-19,31,33-36,44,46-48H,3,9,13-15,17,20H2,1-2H3,(H,41,45)/t31-,33-,34+,35-,36+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 203n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265231
PNG
(3-(3-(8-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tri...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCCCCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C41H51BClF2N3O7/c1-26-21-27(2)47-35(26)24-32-13-12-31(48(32)42(47,44)45)14-18-37(50)46-19-7-5-3-4-6-8-20-54-33-15-9-28(10-16-33)22-30-23-29(11-17-34(30)43)41-40(53)39(52)38(51)36(25-49)55-41/h9-13,15-17,21,23-24,36,38-41,49,51-53H,3-8,14,18-20,22,25H2,1-2H3,(H,46,50)/t36-,38-,39+,40-,41+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 205n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265225
PNG
(3-(3-(4-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tri...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C37H43BClF2N3O7/c1-22-17-23(2)43-31(22)20-28-9-8-27(44(28)38(43,40)41)10-14-33(46)42-15-3-4-16-50-29-11-5-24(6-12-29)18-26-19-25(7-13-30(26)39)37-36(49)35(48)34(47)32(21-45)51-37/h5-9,11-13,17,19-20,32,34-37,45,47-49H,3-4,10,14-16,18,21H2,1-2H3,(H,42,46)/t32-,34-,35+,36-,37+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 267n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265218
PNG
((2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((methyl(7-nitro...)
Show SMILES CN(Cc1ccc(Cc2cc(ccc2Cl)C2OC(CO)C(O)C(O)C2O)cc1)c1ccc([N+]([O-])=O)c2[n-][o+]nc12
Show InChI InChI=1/C27H27ClN4O8/c1-31(19-8-9-20(32(37)38)23-22(19)29-40-30-23)12-15-4-2-14(3-5-15)10-17-11-16(6-7-18(17)28)27-26(36)25(35)24(34)21(13-33)39-27/h2-9,11,21,24-27,33-36H,10,12-13H2,1H3
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 286n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265222
PNG
(3-(3-((2-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CN(CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C36H41BClF2N3O7/c1-21-16-22(2)42-30(21)19-27-8-7-26(43(27)37(42,39)40)9-13-32(45)41(3)14-15-49-28-10-4-23(5-11-28)17-25-18-24(6-12-29(25)38)36-35(48)34(47)33(46)31(20-44)50-36/h4-8,10-12,16,18-19,31,33-36,44,46-48H,9,13-15,17,20H2,1-3H3/t31-,33-,34+,35-,36+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 315n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265180
PNG
(5-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydro...)
Show SMILES CN(Cc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)c1ccc(c(c1)C(O)=O)-c1c2ccc(O)cc2oc2cc(=O)ccc12
Show InChI InChI=1/C42H36ClNO11/c1-44(19-22-4-2-21(3-5-22)14-25-15-23(7-13-32(25)43)40-39(50)38(49)37(48)35(20-45)55-40)41(51)24-6-10-28(31(16-24)42(52)53)36-29-11-8-26(46)17-33(29)54-34-18-27(47)9-12-30(34)36/h2-13,15-18,35,37-40,45-46,48-50H,14,19-20H2,1H3,(H,52,53)/t35-,37-,38+,39-,40+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 350n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265220
PNG
(5-(5-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihyd...)
Show SMILES CN(C)c1ccc2c(-c3ccc(cc3C([O-])=O)C(=O)CCCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)c3ccc(cc3oc2c1)=[N+](C)C
Show InChI InChI=1/C48H49ClN2O10/c1-50(2)31-12-17-35-40(24-31)60-41-25-32(51(3)4)13-18-36(41)43(35)34-16-10-28(23-37(34)48(57)58)39(53)7-5-6-20-59-33-14-8-27(9-15-33)21-30-22-29(11-19-38(30)49)47-46(56)45(55)44(54)42(26-52)61-47/h8-19,22-25,42,44-47,52,54-56H,5-7,20-21,26H2,1-4H3/t42-,44-,45+,46-,47+/s2
UniProtKB/SwissProt

GoogleScholar
CHEBI
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 370n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265221
PNG
(3-(3-(2-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tri...)
Show SMILES Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCOc3ccc(Cc4cc(ccc4Cl)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)=[N+]1[B-]2(F)F
Show InChI InChI=1/C35H39BClF2N3O7/c1-20-15-21(2)41-29(20)18-26-7-6-25(42(26)36(41,38)39)8-12-31(44)40-13-14-48-27-9-3-22(4-10-27)16-24-17-23(5-11-28(24)37)35-34(47)33(46)32(45)30(19-43)49-35/h3-7,9-11,15,17-18,30,32-35,43,45-47H,8,12-14,16,19H2,1-2H3,(H,40,44)/t30-,32-,33+,34-,35+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 420n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265224
PNG
(3-(3-((3-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CN(CCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C37H43BClF2N3O7/c1-22-17-23(2)43-31(22)20-28-9-8-27(44(28)38(43,40)41)10-14-33(46)42(3)15-4-16-50-29-11-5-24(6-12-29)18-26-19-25(7-13-30(26)39)37-36(49)35(48)34(47)32(21-45)51-37/h5-9,11-13,17,19-20,32,34-37,45,47-49H,4,10,14-16,18,21H2,1-3H3/t32-,34-,35+,36-,37+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 430n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265177
PNG
(CHEMBL496518 | N-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-...)
Show SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(CNC(=O)c3ccccc3)cc2)c1
Show InChI InChI=1/C27H28ClNO6/c28-21-11-10-19(26-25(33)24(32)23(31)22(15-30)35-26)13-20(21)12-16-6-8-17(9-7-16)14-29-27(34)18-4-2-1-3-5-18/h1-11,13,22-26,30-33H,12,14-15H2,(H,29,34)/t22-,23-,24+,25-,26+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 495n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM20875
PNG
(1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihyd...)
Show SMILES OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O
Show InChI InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1
UniProtKB/SwissProt

GoogleScholar
Purchase

CHEBI
CHEMBL
KEGG
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 752n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265219
PNG
(5-(5-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihyd...)
Show SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(OCCCCC(=O)c3ccc(c(c3)C(O)=O)-c3c4ccc(O)cc4oc4cc(=O)ccc34)cc2)c1
Show InChI InChI=1/C44H39ClO12/c45-34-15-7-25(43-42(52)41(51)40(50)38(22-46)57-43)18-26(34)17-23-4-10-29(11-5-23)55-16-2-1-3-35(49)24-6-12-30(33(19-24)44(53)54)39-31-13-8-27(47)20-36(31)56-37-21-28(48)9-14-32(37)39/h4-15,18-21,38,40-43,46-47,50-52H,1-3,16-17,22H2,(H,53,54)/t38-,40-,41+,42-,43+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 835n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265227
PNG
(3-(3-((4-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CCCN(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C40H49BClF2N3O7/c1-4-17-45(36(49)16-12-30-10-11-31-23-34-25(2)20-26(3)46(34)41(43,44)47(30)31)18-5-6-19-53-32-13-7-27(8-14-32)21-29-22-28(9-15-33(29)42)40-39(52)38(51)37(50)35(24-48)54-40/h7-11,13-15,20,22-23,35,37-40,48,50-52H,4-6,12,16-19,21,24H2,1-3H3/t35-,37-,38+,39-,40+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 850n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265228
PNG
(3-(3-((4-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CC(C)N(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C40H49BClF2N3O7/c1-24(2)45(36(49)16-12-30-10-11-31-22-34-25(3)19-26(4)46(34)41(43,44)47(30)31)17-5-6-18-53-32-13-7-27(8-14-32)20-29-21-28(9-15-33(29)42)40-39(52)38(51)37(50)35(23-48)54-40/h7-11,13-15,19,21-22,24,35,37-40,48,50-52H,5-6,12,16-18,20,23H2,1-4H3/t35-,37-,38+,39-,40+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.57E+3n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265229
PNG
(3-(3-((4-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-tr...)
Show SMILES CC(C)CN(CCCCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCC1=[N+]2C(C=C1)=Cc1c(C)cc(C)n1[B-]2(F)F
Show InChI InChI=1/C41H51BClF2N3O7/c1-25(2)23-46(37(50)16-12-31-10-11-32-22-35-26(3)19-27(4)47(35)42(44,45)48(31)32)17-5-6-18-54-33-13-7-28(8-14-33)20-30-21-29(9-15-34(30)43)41-40(53)39(52)38(51)36(24-49)55-41/h7-11,13-15,19,21-22,25,36,38-41,49,51-53H,5-6,12,16-18,20,23-24H2,1-4H3/t36-,38-,39+,40-,41+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.00E+3n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265183
PNG
((2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((7-nitrobenzo[c...)
Show SMILES OCC1OC(C(O)C(O)C1O)c1ccc(Cl)c(Cc2ccc(CNc3ccc([N+]([O-])=O)c4[n-][o+]nc34)cc2)c1
Show InChI InChI=1/C26H25ClN4O8/c27-17-6-5-15(26-25(35)24(34)23(33)20(12-32)38-26)10-16(17)9-13-1-3-14(4-2-13)11-28-18-7-8-19(31(36)37)22-21(18)29-39-30-22/h1-8,10,20,23-26,28,32-35H,9,11-12H2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.40E+3n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265181
PNG
(5-(6-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihyd...)
Show SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(CNC(=O)CCCCCNC(=O)c3ccc(c(c3)C(O)=O)-c3c4ccc(O)cc4oc4cc(=O)ccc34)cc2)c1
Show InChI InChI=1/C47H45ClN2O12/c48-36-16-10-27(45-44(57)43(56)42(55)39(24-51)62-45)19-29(36)18-25-5-7-26(8-6-25)23-50-40(54)4-2-1-3-17-49-46(58)28-9-13-32(35(20-28)47(59)60)41-33-14-11-30(52)21-37(33)61-38-22-31(53)12-15-34(38)41/h5-16,19-22,39,42-45,51-52,55-57H,1-4,17-18,23-24H2,(H,49,58)(H,50,54)(H,59,60)/t39-,42-,43+,44-,45+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 8.00E+3n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265179
PNG
(5-(4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydrox...)
Show SMILES OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(CNC(=O)c3ccc(c(c3)C(O)=O)-c3c4ccc(O)cc4oc4cc(=O)ccc34)cc2)c1
Show InChI InChI=1/C41H34ClNO11/c42-31-12-6-22(39-38(49)37(48)36(47)34(19-44)54-39)14-24(31)13-20-1-3-21(4-2-20)18-43-40(50)23-5-9-27(30(15-23)41(51)52)35-28-10-7-25(45)16-32(28)53-33-17-26(46)8-11-29(33)35/h1-12,14-17,34,36-39,44-45,47-49H,13,18-19H2,(H,43,50)(H,51,52)/t34-,36-,37+,38-,39+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.10E+4n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
Sodium/glucose cotransporter 2 (SGLT2)


(Homo sapiens (Human))
BDBM50265182
PNG
(5-(6-((4-(2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihy...)
Show SMILES CN(Cc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1)C(=O)CCCCCNC(=O)c1ccc(c(c1)C(O)=O)-c1c2ccc(O)cc2oc2cc(=O)ccc12
Show InChI InChI=1/C48H47ClN2O12/c1-51(24-27-8-6-26(7-9-27)19-30-20-28(11-17-37(30)49)46-45(58)44(57)43(56)40(25-52)63-46)41(55)5-3-2-4-18-50-47(59)29-10-14-33(36(21-29)48(60)61)42-34-15-12-31(53)22-38(34)62-39-23-32(54)13-16-35(39)42/h6-17,20-23,40,43-46,52-53,56-58H,2-5,18-19,24-25H2,1H3,(H,50,59)(H,60,61)/t40-,43-,44+,45-,46+/s2
UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.51E+4n/an/an/an/an/an/a



Pfizer Global Research and Development

Curated by ChEMBL


Assay Description
Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay


Bioorg Med Chem Lett 18: 4944-7 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.036
BindingDB Entry DOI: 10.7270/Q27944J7
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%